Role of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Anemia in CKD: Key Considerations for Pharmacists

This activity includes animated videos.

Program Description

Anemia is a common complication of CKD and is associated with poor clinical outcomes and leads to a substantial burden on patients and healthcare systems, particularly when left untreated or undertreated. It is often poorly diagnosed and undertreated in patients with early-stage CKD. Early detection and effective management of anemia in the setting of CKD is needed to minimize the debilitating effects it may have on patients’ quality of life. Traditional treatment strategies are limited due to adverse complications, highlighting the need for novel therapies. The identified gaps indicate a need to educate pharmacists about current and emerging strategies to treat and manage anemia of CKD. Continuing professional education will improve pharmacist’s knowledge of this condition and ability to translate evidence about available treatments that may be initiated to manage the effects of anemia of CKD. Application of this knowledge including evidenced based treatment and individualized patient education will enable pharmacists to enhance patients’ health-related quality of life and reduce direct and indirect costs of the disease.

Target Audience: Health-system pharmacists and retail pharmacists

Type of Activity: Application
Release date: June 2, 2022
Expiration date: June 2, 2023

Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explain the prevalence, pathophysiology, and complications of anemia in chronic kidney disease (CKD)

• Identify the current challenges in standards of care with treating anemia in CKD

• Examine the role of hypoxia-inducible factor prolyl hydroxylase inhibitors and novel therapies under investigation in this drug class

• Illustrate the role of the pharmacist and evidence-based best practices to develop strategies that effectively treat anemia in patients with CKD

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-22-281-H01-P. The activity is available for CE credit through June 2, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the symposium in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Thomas C. Dowling, PharmD, PhD, FCCP has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms